-
-
-
-
-
-
-
Neurophet receives FDA clearance for Alzheimer's imaging software
-
-
-
-
-
-
-
Pulmovant completes enrollment in phase 2 trial for lung disease drug
-
-
-
-
-
-
-
Hims & Hers Health (HIMS) launches a copy of Wegovy pill at $49/month
-
-
-
-
-
-
-
Cognition Therapeutics extends drug access program for dementia patients
-
-
-
-
-
-
-
Oncolytics receives FDA fast track for colorectal cancer treatment
-
-
-
-
-
-
-
BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
-
-
-
-
-
-
-
Quanterix submits FDA application for Alzheimer blood test
-
73,938 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

